Feature
Commentary: Evaluating and regulating device therapy
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2839 (Published 14 May 2011) Cite this as: BMJ 2011;342:d2839
Related articles
- Feature Published: 14 May 2011; BMJ 342 doi:10.1136/bmj.d2952
- Feature Published: 14 May 2011; BMJ 342 doi:10.1136/bmj.d2748
- Feature Published: 14 May 2011; BMJ 342 doi:10.1136/bmj.d2826
- Analysis Published: 14 May 2011; BMJ 342 doi:10.1136/bmj.d2973
- Feature Published: 14 May 2011; BMJ 342 doi:10.1136/bmj.d3021
- Editor's Choice Published: 18 May 2011; BMJ 342 doi:10.1136/bmj.d3123
- Letter Published: 07 June 2011; BMJ 342 doi:10.1136/bmj.d3540
- Research Published: 28 June 2016; BMJ 353 doi:10.1136/bmj.i3323
See more
- Cancer drugs remain FDA approved despite lack of benefit, study findsBMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568
- Johnson & Johnson is ordered to pay $1bn over faulty hip implantsBMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551
- Bill to boost medical research funding and speed drug approval passes US houseBMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498
- Trial of novel leukaemia drug is stopped for second time after two more deathsBMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376
- Promise of new Alzheimer’s drug is dashed after lack of evidenceBMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362
Cited by...
- Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study
- Keeping patients safe while avoiding bias in randomised trials
- Wanted: an appropriate evaluation template